DelMar Pharmaceuticals Inc (Nasdaq: DMPI), a biopharmaceutical company focused on the development and commercialisation of new cancer therapies, announced yesterday that it has named three oncologists to its Scientific Advisory Board.
The company has added Dr David Reardon, clinical director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and a professor of medicine at the Harvard Medical School to its Scientific Advisory Board; Dr Timothy Cloughesy, professor of neurology at the David Geffen School of Medicine at the University of California, Los Angeles and a member of the UCLA Brain Research Institute and Jonsson Comprehensive Cancer Center; Dr Nicholas Butowski, a neuro-oncologist practicing at UCSF Medical Center in San Francisco, California, and director of translational research in neuro-oncology and a researcher at the Brain Tumor Center.
These new advisors join the present Scientific Advisory Board members Dr John de Groot, chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Centre and Dr Napoleone Ferrara, scientist and distinguished professor of pathology and a distinguished adjunct professor of ophthalmology and pharmacology at the University of California, San Diego. Dr Ferrara will serve as chairman of the company's Scientific Advisory Board.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business